-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Poseida Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2020 to Q1 2024.
- Poseida Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$15.1M, a 60.2% increase year-over-year.
- Poseida Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$92.2M, a 244% decline from 2022.
- Poseida Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$26.8M, a 73.9% increase from 2021.
- Poseida Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$103M, a 9.52% increase from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)